Search research articles
Contact Us
Filters
Showing results (91-100 of 107) with videos related to
Page
of 11
Sort By:
FEBS Open Bio
|
January 29, 2021
Uptake of circulating extracellular vesicles from rectal cancer patients and differential responses by human monocyte cultures
Tonje Bjørnetrø, Lilly Alice Steffensen, Beate Vestad, et al.
British Journal of Cancer
|
February 23, 2026
Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancer
Anne Hansen Ree, Paula A Bousquet, Tina Visnovska, et al.
Thrombosis Research
|
September 12, 2020
Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism
Trine-Lise Hannevik, Jorunn Brekke, Tone Enden, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 21, 2022
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply
Trine-Lise Larsen, Herish Garresori, Jorunn Brekke, et al.
Oncoimmunology
|
July 2, 2024
Complete response of metastatic microsatellite-stable <i>BRAF</i> V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade
Anne Hansen Ree, Eirik Høye, Ying Esbensen, et al.
Journal of Extracellular Biology
|
November 3, 2025
Dissemination of Mitochondrial DNA Variants: Looking at the 'Bigger' Picture of the Tumour Microenvironment in Rectal Cancer Patients
Kine Mari Bakke, Tonje Bjørnetrø, Paula A Bousquet, et al.
Translational Oncology
|
May 17, 2019
A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases
Vivi Ann Flørenes, Karine Flem-Karlsen, Erin McFadden, et al.
Thrombosis Research
|
June 16, 2023
Arterial events in cancer patients treated with apixaban for venous thrombosis
Trine-Lise Larsen, Marte Svalastoga, Jorunn Brekke, et al.
JCO Precision Oncology
|
April 27, 2022
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series
Margherita Ambrosini, Marzia Del Re, Paolo Manca, et al.
Clinical and Translational Radiation Oncology
|
December 25, 2019
Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?
Sebastian Meltzer, Kine Mari Bakke, Karina Lund Rød, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 107) with videos related to
Sort By:
Page
of 11
FEBS Open Bio
|
January 29, 2021
Uptake of circulating extracellular vesicles from rectal cancer patients and differential responses by human monocyte cultures
Tonje Bjørnetrø, Lilly Alice Steffensen, Beate Vestad, et al.
British Journal of Cancer
|
February 23, 2026
Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancer
Anne Hansen Ree, Paula A Bousquet, Tina Visnovska, et al.
Thrombosis Research
|
September 12, 2020
Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism
Trine-Lise Hannevik, Jorunn Brekke, Tone Enden, et al.
Journal of Thrombosis and Haemostasis : JTH
|
July 21, 2022
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply
Trine-Lise Larsen, Herish Garresori, Jorunn Brekke, et al.
Oncoimmunology
|
July 2, 2024
Complete response of metastatic microsatellite-stable <i>BRAF</i> V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade
Anne Hansen Ree, Eirik Høye, Ying Esbensen, et al.
Journal of Extracellular Biology
|
November 3, 2025
Dissemination of Mitochondrial DNA Variants: Looking at the 'Bigger' Picture of the Tumour Microenvironment in Rectal Cancer Patients
Kine Mari Bakke, Tonje Bjørnetrø, Paula A Bousquet, et al.
Translational Oncology
|
May 17, 2019
A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases
Vivi Ann Flørenes, Karine Flem-Karlsen, Erin McFadden, et al.
Thrombosis Research
|
June 16, 2023
Arterial events in cancer patients treated with apixaban for venous thrombosis
Trine-Lise Larsen, Marte Svalastoga, Jorunn Brekke, et al.
JCO Precision Oncology
|
April 27, 2022
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case Series
Margherita Ambrosini, Marzia Del Re, Paolo Manca, et al.
Clinical and Translational Radiation Oncology
|
December 25, 2019
Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?
Sebastian Meltzer, Kine Mari Bakke, Karina Lund Rød, et al.
Page
of 11